Condition
Cumulus Cell
Total Trials
3
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting2
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05332769Active Not Recruiting
Cumulus Cell Mitochondrial Activity as a Non-invasive Marker of Embryo Quality (FLIM)
NCT07197255Recruiting
Transcriptomic Profiling of Cumulus Cells From CAPA-IVM
NCT06315777Not ApplicableRecruiting
GREM1, HAS2 and PTGS2 Gene Expression Following the in Vitro Maturation (IVM)
Showing all 3 trials